NCT04450134View on ClinicalTrials.gov

Histamine H1/H2 Receptors and Training Adaptations

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

December 18, 2019

Study Completion Date

April 14, 2021

Conditions
Exercise TrainingPhysical Activity
Interventions
OTHER

Lactose

Placebo: Lactose capsules

DRUG

Fexofenadine Hydrochloride

H1 receptor antagonist: 540 mg Fexofenadine Hydrochloride

DRUG

Famotidine

H2 receptor antagonist: 40 mg Famotidine

OTHER

High-intensity interval training (HIIT)

6 weeks HIIT

Trial Locations (1)

9000

Department of Movement and Sports Sciences, Ghent University, Ghent

All Listed Sponsors
collaborator

Research Foundation Flanders

OTHER

collaborator

University of Copenhagen

OTHER

lead

University Ghent

OTHER

NCT04450134 - Histamine H1/H2 Receptors and Training Adaptations | Biotech Hunter | Biotech Hunter